Valsartan

F Ardiana, G Indrayanto - Profiles of drug substances, excipients and …, 2015 - Elsevier
Valsartan is an antihypertensive drug which selectively inhibits angiotensin receptor type II.
Generally, valsartan is available as film-coated tablets. This review summarizes thermal …

High performance thin-layer and high performance liquid chromatography coupled with photodiode array and fluorescence detectors for analysis of valsartan and …

MAA Ragab, SM Galal, MA Korany… - Journal of …, 2018 - academic.oup.com
Valsartan (VAL) and sacubitril (SAC) are combined in a supramolecular complex, LCZ696,
which is a newly approved remedy for heart failure. SAC-related substance (biphenyl methyl …

Development and validation of ultraviolet spectrophotometric method for Saquinavir estimation in bulk and dosage form

T Mujawar, S Ahmad, P Tajane, V Sable… - Multidisciplinary …, 2023 - malquepub.com
We developed and validated a simple, rapid, sensitive, precise, and reproducible specific
UV spectrophotometric technique for determining Saquinavir in bulk medication and …

[PDF][PDF] Design, development and fabrication of mouth-dissolving tablets containing extract of Tribulus terrestris for the treatment of hypertension

L BARDE, P SURUSE, S AGRAWAL… - Int J App …, 2023 - researchgate.net
DESIGN, DEVELOPMENT AND FABRICATION OF MOUTH-DISSOLVING TABLETS
CONTAINING EXTRACT OF TRIBULUS TERRESTRIS FOR THE TREATMENT OF H Page …

[PDF][PDF] First derivative spectrophotometric method for the simultaneous estimation of valsartan and hydrochlorthiazide in their combined dosage form

NR Patel, SK Patel - Int. J. Pharm. And Life sci, 2012 - Citeseer
The present manuscript describe simple, sensitive, rapid, accurate, precise and cost
effective First derivative spectrophotometric zero crossing point method for the simultaneous …

[PDF][PDF] A concise review on analytical profile of valsartan

AA Shirkhedkar, SR Chaudhari… - Eurasian Journal of …, 2017 - pdfs.semanticscholar.org
Valsartan (VAL) is an orally active angiotensin-II receptor type-I antagonist. VAL is available
alone in dosage form as well as multicomponent formulation with various antihypertensive …

[PDF][PDF] Estimation of losartan potassium and ramipril in their combined dosage form by validated HPTLC method

KB Bodiwala, K Mali, P Patel, PB Prajapati… - Eurasian Journal of …, 2017 - academia.edu
ABSTRACT A sensitive, specific and precise high performance thin layer chromatographic
method for estimation of Losartan potassium (LOS) and Ramipril (RAM) has been …

[PDF][PDF] FORCED DEGRADATION STUDIES FOR DRUG SUBSTANCES AND DRUG PRODUCTS-OVERVIEW OF REGULATORY GUIDANCE

Y Wankhede, AB Darekar - 2024 - wjpr.s3.ap-south-1.amazonaws.com
When developing stability-indicating methods, especially when there is minimal data about
probable degradation products, forced degradation or stress testing is intended to control …

Drug profile of valsartan: a review

B Kumari, R Garg - World Journal of Pharmaceutical Sciences, 2015 - wjpsonline.com
Valsartan is a new potent, highly selective and orally active antihypertensive drug belonging
to the family of Angiotensin II type I receptor antagonists. Angiotensin II receptor type I …

[PDF][PDF] Design, Development and Physicochemical Evaluation of Effervescent Tablets of Antihistamine Drug

V Nikam, A Bhosale - academia.edu
Purpose: Effervescent bilastine tablets were the focus of this investigation because of their
ease of administration and the fact that some patients, especially younger ones or those with …